What does Médecine générale VERHAEREN -GOFFARD do?

Médecine générale VERHAEREN -GOFFARD is a research organisation in Theux. Private Limited, started on 14 May 2008, 1 establishment.

What is the address of Médecine générale VERHAEREN -GOFFARD?

The registered office of Médecine générale VERHAEREN -GOFFARD is located at Place du Vinave 17, 4910 Theux.

Is Médecine générale VERHAEREN -GOFFARD still active?

Yes. According to the CBE (18 September 2026) Médecine générale VERHAEREN -GOFFARD is active, legal situation “Normale toestand”, started on 14 May 2008.

Is Médecine générale VERHAEREN -GOFFARD registered on Peppol?

No, Médecine générale VERHAEREN -GOFFARD is currently not registered on the Peppol network.

What is the enterprise number of Médecine générale VERHAEREN -GOFFARD?

The enterprise number of Médecine générale VERHAEREN -GOFFARD is BE0898042232.

When was Médecine générale VERHAEREN -GOFFARD founded?

Médecine générale VERHAEREN -GOFFARD was founded on 14 May 2008.

Who are the directors of Médecine générale VERHAEREN -GOFFARD?

According to the 2025 annual accounts, the directors of Médecine générale VERHAEREN -GOFFARD are: Guy Verhaeren.

Is Médecine générale VERHAEREN -GOFFARD a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 May 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Médecine générale VERHAEREN -GOFFARD make in 2025?

Médecine générale VERHAEREN -GOFFARD posted a profit after taxes of € 134,285 in financial year 2025.

What is the revenue of Médecine générale VERHAEREN -GOFFARD?

As a small company, Médecine générale VERHAEREN -GOFFARD is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 222,690.

Médecine générale VERHAEREN -GOFFARD (Private Limited)

Dossier Médecine générale VERHAEREN -GOFFARD, printed on 18 September 2026 from databakkes.be/en/0898042232/medecine-generale-verhaeren-goffard. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Médecine générale VERHAEREN -GOFFARD from Theux, company number BE0898042232, closed financial year 2025 with a result of € 134,285 after tax. For that financial year Médecine générale VERHAEREN -GOFFARD recorded a gross margin of € 222,690 and equity of € 888,084. Compared with financial year 2024, the result moved from € 157,383 to € 134,285. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 888,084

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 134,285

▼ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 861,885

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 881,884.

People and assets in 2025

Vehicles and equipment

€ 36,653

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,207

▲ € 8,817 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 82,862

▼ 6% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 172,259 Gross margin 2022: € 172,259 First fiscal year in the series	€ 231,347 Gross margin 2023: € 231,347 ▲ 34% vs 2022 (€ 172,259) Favourable step	€ 254,748 Gross margin 2024: € 254,748 ▲ 10% vs 2023 (€ 231,347) Favourable step	€ 222,690 Gross margin 2025: € 222,690 ▼ 13% vs 2024 (€ 254,748) Unfavourable step	▼ 13%
Profit after taxes	€ 116,538 Profit after taxes 2022: € 116,538 First fiscal year in the series	€ 148,922 Profit after taxes 2023: € 148,922 ▲ 28% vs 2022 (€ 116,538) Favourable step	€ 157,383 Profit after taxes 2024: € 157,383 ▲ 6% vs 2023 (€ 148,922) Favourable step	€ 134,285 Profit after taxes 2025: € 134,285 ▼ 15% vs 2024 (€ 157,383) Unfavourable step	▼ 15%
Equity	€ 447,494 Equity 2022: € 447,494 First fiscal year in the series	€ 596,416 Equity 2023: € 596,416 ▲ 33% vs 2022 (€ 447,494) Favourable step	€ 753,799 Equity 2024: € 753,799 ▲ 26% vs 2023 (€ 596,416) Favourable step	€ 888,084 Equity 2025: € 888,084 ▲ 18% vs 2024 (€ 753,799) Favourable step	▲ 18%
Total debts	€ 63,450 Total debts 2022: € 63,450 First fiscal year in the series	€ 83,489 Total debts 2023: € 83,489 ▲ 32% vs 2022 (€ 63,450) Unfavourable step	€ 88,827 Total debts 2024: € 88,827 ▲ 6% vs 2023 (€ 83,489) Unfavourable step	€ 92,139 Total debts 2025: € 92,139 ▲ 4% vs 2024 (€ 88,827) Unfavourable step	▲ 4%
Cash	€ 420,817 Cash 2022: € 420,817 First fiscal year in the series	€ 542,648 Cash 2023: € 542,648 ▲ 29% vs 2022 (€ 420,817) Favourable step	€ 707,305 Cash 2024: € 707,305 ▲ 30% vs 2023 (€ 542,648) Favourable step	€ 861,885 Cash 2025: € 861,885 ▲ 22% vs 2024 (€ 707,305) Favourable step	▲ 22%
Land & buildings	€ 1,908 Land & buildings 2022: € 1,908 First fiscal year in the series	€ 639 Land & buildings 2023: € 639 ▼ 67% vs 2022 (€ 1,908) Unchanged	€ 127 Land & buildings 2024: € 127 ▼ 80% vs 2023 (€ 639) Unchanged	€ 0 Land & buildings 2025: € 0 ▼ 100% vs 2024 (€ 127) Unchanged	▼ 100%
Retained profit	€ 441,294 Retained profit 2022: € 441,294 First fiscal year in the series	€ 590,216 Retained profit 2023: € 590,216 ▲ 34% vs 2022 (€ 441,294) Favourable step	€ 747,599 Retained profit 2024: € 747,599 ▲ 27% vs 2023 (€ 590,216) Favourable step	€ 881,884 Retained profit 2025: € 881,884 ▲ 18% vs 2024 (€ 747,599) Favourable step	▲ 18%
Dividend	€ 60,000 Dividend 2022: € 60,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 60,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 510,944 Balance sheet total 2022: € 510,944 First fiscal year in the series	€ 679,905 Balance sheet total 2023: € 679,905 ▲ 33% vs 2022 (€ 510,944) Unchanged	€ 842,626 Balance sheet total 2024: € 842,626 ▲ 24% vs 2023 (€ 679,905) Unchanged	€ 980,223 Balance sheet total 2025: € 980,223 ▲ 16% vs 2024 (€ 842,626) Unchanged	▲ 16%

Key figures of Médecine générale VERHAEREN -GOFFARD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Médecine générale VERHAEREN -GOFFARD?

What happened at Médecine générale VERHAEREN -GOFFARD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 134,285 (▼ 15% vs 2024). filed late Source: NBB ↗
May 21, 2008 New establishment in Theux. KBO
May 14, 2008 Start of the company according to the CBE. KBO

In short

From € 116,538 profit in 2022 to € 134,285 profit in 2025.

Paid € 270,747 in corporate taxes since 2022.

Best year ever: 2024, with € 157,383 profit.

Paid out € 60,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Médecine générale VERHAEREN -GOFFARD? We notify you, reason included.

Follow Médecine générale VERHAEREN -GOFFARD

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Guy Verhaeren

Médecine générale VERHAEREN -GOFFARD

Behind Médecine générale VERHAEREN -GOFFARD is Guy Verhaeren.

See the full network in the app

Directors

According to the 2025 annual accounts

Guy Verhaeren

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Place du Vinave 17

4910 Theux

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0898.042.232

VAT number

BE 0898.042.232

Registered office

Place du Vinave 17, 4910 Theux

Names & denominations

Médecine générale VERHAEREN -GOFFARD

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 May 2008

Peppol

Not registered

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Médecine générale VERHAEREN -GOFFARD

Warning lights

Financials

What happened to Médecine générale VERHAEREN -GOFFARD?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions